Combination of the effect of ginger and anti‐inflammatory diet on children with obesity with nonalcoholic fatty liver disease: A randomized clinical trial
Open Access
- 24 January 2023
- journal article
- research article
- Published by Wiley in Food Science & Nutrition
- Vol. 11 (4) , 1846-1859
Abstract
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease in children. Following earlier reports on an increase in the prevalence of childhood obesity, NAFLD is now becoming increasingly common in children. Although no definitive cure exists, early management, early diagnosis, and treatment can reduce its complications. This study aims to determine the effectiveness of the combination of ginger and an anti‐inflammatory diet (AID) in children with obesity on fatty liver management. This randomized clinical trial was conducted on 160 children with obesity aged 8–11 years, with a mean (SD) weight of 65.01 (9.67) kg, mean (SD) height of 139.87 (7.37) cm, and mean (SD) body mass index of 33.40 (5.59) kg/m2. The study duration was 12 weeks. Children were divided into four groups: ginger (G), AID, ginger plus an AID (GPA), and control. Ginger capsules comprised 1000 mg of ginger, whereas the AID comprised fruits and vegetables, fish, turkey, and chicken (without skin) with lean meat, omega‐3 sources, nuts, legumes, probiotic products, and elimination of inflammatory food. Following the intervention, serum fasting blood sugar and high‐sensitivity C‐reactive protein levels were significantly decreased in the AID (p = .006 and .002, respectively), G (p = .04 and <.001, respectively), and GPA (p <.001 in both cases, respectively) groups. Further, in the G and GPA groups, there was a significant decrease in body mass index (p = .04 in both cases, respectively), waist circumference (p = .009 and .003, respectively), waist‐to‐height ratio (p = .02 and .005, respectively), alanine aminotransferase (p = .004 and <.001, respectively), total cholesterol (p = .0002 and .0001, respectively) and low‐density lipoprotein‐cholesterol (p < .001 and <.001, respectively). Eventually, serum aspartate aminotransferase was decreased (p < .001) and high‐density lipoprotein‐cholesterol (p = .03) was increased significantly in the GPA group. As a main finding of this study, hepatic steatosis significantly decreased in the G and GPA groups. Ginger supplementation can effectively improve NAFLD in children, and its effectiveness was further increased when combined with an AID.Keywords
Funding Information
- Kermanshah University of Medical Sciences
This publication has 46 references indexed in Scilit:
- Biophysical Characteristics of Meridians and Acupoints: A Systematic ReviewEvidence-Based Complementary and Alternative Medicine, 2012
- Investigation of anthropometric, biochemical and dietary parameters of obese children with and without non-alcoholic fatty liver diseaseAppetite, 2012
- Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patientsEuropean Journal of Clinical Nutrition, 2012
- Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic ratsFood and Chemical Toxicology, 2011
- Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in ratsInflammopharmacology, 2010
- Protective Effects of Ethanolic Extract of Zingiber officinale Rhizome on the Development of Metabolic Syndrome in High‐Fat Diet‐Fed RatsBasic & Clinical Pharmacology & Toxicology, 2009
- Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory ActionsJournal of Medicinal Food, 2005
- Effect of ethanolic extract of Zingiber officinale on dyslipidaemia in diabetic ratsJournal of Ethnopharmacology, 2005
- Hepatic steatosis in obese Chinese childrenInternational Journal of Obesity, 2004
- Inhibitory effects of [6]‐gingerol on PMA‐induced COX‐2 expression and activation of NF‐κB and p38 MAPK in mouse skinBioFactors, 2004